Skip to main content

and
  1. Article

    Open Access

    Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women

    Pure mucinous carcinoma (MC) is found in about 3.5% of all newly diagnosed breast cancer patients in Taiwan. MC is a relatively rare malignancy of breast cancer, and its nature, behaviors, treatment pattern an...

    Hsin-Shun Tseng, Che Lin, Szu-Erh Chan, Su-Yu Chien in World Journal of Surgical Oncology (2013)

  2. No Access

    Article

    A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers

    Preclinical data indicate that the combination of docetaxel, cisplatin and trastuzumab (TCH) may have the potential for clinically significant activity against breast cancers that overexpress the her2/neu gene...

    Che Lin, Dar-Ren Chen, King-Jen Chang in Cancer Chemotherapy and Pharmacology (2012)

  3. Article

    Open Access

    Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions?

    The aims of this study were to determine the accuracy of concurrent core needle biopsy (CNB) and fine needle aspiration biopsy (FNAB) for breast lesions and to estimate the false-negative rate using the two me...

    Yao-Lung Kuo, Tsai-Wang Chang in BMC Cancer (2010)

  4. Article

    Open Access

    Triple negative breast carcinoma is a prognostic factor in Taiwanese women

    Currently, there is a debate as to whether triple negative breast carcinoma (TNBC) has a worse prognosis than non-TNBC. Our aim was to determine whether TNBC is a prognostic factor for survival.

    Che Lin, Su-Yu Chien, Li-Sheng Chen, Shou-Jen Kuo, Tsai-Wang Chang in BMC Cancer (2009)